Why is Ajooni Biotech falling/rising?

As of 25-Jun, Ajooni Biotech Ltd's stock price is currently at 6.05, reflecting a slight increase of 0.02 or 0.33%. The stock has shown a strong performance over the past week, rising by 8.04%, and has outperformed the benchmark Sensex, which increased by only 1.74% during the same period. Today's price summary indicates that the stock is trading above its 5-day, 20-day, and 50-day moving averages, although it remains below its 100-day and 200-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 714.13% against the 5-day average. The company has also reported positive results for the last three consecutive quarters, with net sales growing by 49.49% and a profit after tax reaching its highest at Rs 1.54 crore, contributing to a one-year return of 20.04%, which is substantially higher than the market average.
In the broader market context, Ajooni Biotech's recent short-term performance has significantly outpaced the benchmark, as evidenced by its 8.04% gain over the past week compared to the Sensex's 1.74%. However, despite these positive short-term movements, the company faces challenges in the long term, including a weak return on capital employed and poor debt servicing capabilities. These factors may dampen investor sentiment moving forward, despite the attractive valuation and recent positive sales growth. Overall, while the stock is currently rising, its long-term fundamentals suggest caution among investors.